Clinical and virologic manifestations of primary Epstein-Barr virus (EBV) infection in Kenyan infants born to HIV-infected women

Journal of Infectious Diseases

Volumn 207, Issue 12, 2013, Pages 1798-1806

  Slyker, Jennifer A ^a   Casper, Corey ^a,b   Tapia, Kenneth ^a,c   Richardson, Barbra ^a,b,c   Bunts, Lisa ^b   Huang, Meei Li ^a   Maleche Obimbo, Elizabeth ^c   Nduati, Ruth ^c   John Stewart, Grace ^a,d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF NAIROBI   (Kenya)

^d Department of Pediatrics ^*  (United States)

Author keywords

EBV; herpesviruses; HIV; pediatric; primary infection

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CHILD HOSPITALIZATION; CLINICAL EXAMINATION; CLINICAL FEATURE; COHORT ANALYSIS; CONJUNCTIVITIS; CONTROLLED STUDY; COUGHING; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS INFECTION; FEMALE; FEVER; HEPATOMEGALY; HIGH RISK INFANT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION RISK; KENYA; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OTITIS MEDIA; PEDIATRICIAN; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHINORRHEA; SERODIAGNOSIS; SPLENOMEGALY; VIRUS LOAD; VIRUS TRANSMISSION;

EBV; HERPESVIRUSES; HIV; PEDIATRIC; PRIMARY INFECTION;

ADULT; ANTIBODIES, VIRAL; COHORT STUDIES; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HIV INFECTIONS; HUMANS; INCIDENCE; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; KENYA; LONGITUDINAL STUDIES; MALE; RISK FACTORS; VIRAL LOAD; VIREMIA; YOUNG ADULT;

EID: 84878003889     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit093     Document Type: Article

References (41)

1. Svahn A, Berggren J, Parke A, Storsaeter J, Thorstensson R, Linde A. Changes in seroprevalence to four herpesviruses over 30 years in Swedish children aged 9-12 years. J Clin Virol 2006; 37:118-23.
2. Niederman JC, Evans AS, Subrahmanyan L, McCollum RW. Prevalence, incidence and persistence of EB virus antibody in young adults. N Engl J Med 1970; 282:361-5.
3. Biggar RJ, Henle W, Fleisher G, Bocker J, Lennette ET, Henle G. Primary Epstein-Barr virus infections in African infants. I. Decline of maternal antibodies and time of infection. Int J Cancer 1978; 22:239-43.
4. Kafuko GW, Henderson BE, Kirya BG, et al. Epstein-Barr virus antibody levels in children from the West Nile District of Uganda. Report of a field study. Lancet 1972; 1:706-9.
5. Martro E, Bulterys M, Stewart JA, et al. Comparison of human herpesvirus 8 and Epstein-Barr virus seropositivity among children in areas endemic and non-endemic for Kaposi's sarcoma. J Med Virol 2004; 72:126-31.
6. Piriou E, Asito AS, Sumba PO, et al. Early age at time of primary Epstein-Barr virus infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma. J Infect Dis 2012; 205:906-13.
7. Bauer CC, Aberle SW, Popow-Kraupp T, Kapitan M, Hofmann H, Puchhammer-Stockl E. Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection. J Med Virol 2005; 75:54-8.
8. Balfour HH Jr., Holman CJ, Hokanson KM, et al. A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis. J Infect Dis 2005; 192:1505-12.
9. Jenson H, McIntosh K, Pitt J, et al. Natural history of primary Epstein-Barr virus infection in children of mothers infected with human immunodeficiency virus type 1. J Infect Dis 1999; 179:1395-404.
10. Henle G, Henle W, Diehl V. Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis. Proc Natl Acad Sci USA 1968; 59:94-101.
11. Biggar RJ, Henle G, Bocker J, Lennette ET, Fleisher G, Henle W. Primary Epstein-Barr virus infections in African infants. II. Clinical and serological observations during seroconversion. Int J Cancer 1978; 22:244-50.
12. Sumaya CV. Primary Epstein-Barr virus infections in children. Pediatrics 1977; 59:16-21.
13. Pedneault L, Lapointe N, Alfieri C, et al. Natural history of Epstein-Barr virus infection in a prospective pediatric cohort born to human immunodeficiency virus-infected mothers. J Infect Dis 1998; 177:1087-90.
14. Henke CE, Kurland LT, Elveback LR. Infectious mononucleosis in Rochester, Minnesota, 1950 through 1969. Am J Epidemiol 1973; 98:483-90.
15. Kutok JL, Wang F. Spectrum of Epstein-Barr virus-associated diseases. Annu Rev Pathol 2006; 1:375-404.
16. Hjalgrim H, Askling J, Rostgaard K, et al. Characteristics of Hodgkin's lymphoma after infectious mononucleosis. N Engl J Med 2003; 349:1324-32.
17. de-The G, Geser A, Day NE, et al. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature 1978; 274: 756-61.
18. Burkitt DP. Epidemiology of Burkitt's lymphoma. Proc R Soc Med 1971; 64:909-10.
19. Burkitt D. A sarcoma involving the jaws in African children. Br J Surg 1958; 46:218-23.
20. Orem J, Mulumba Y, Algeri S, et al. Clinical characteristics, treatment and outcome of childhood Burkitt's lymphoma at the Uganda Cancer Institute. Trans R Soc Trop Med Hyg 2011; 105:717-26.
21. Biggar RJ, Frisch M, Goedert JJ. Risk of cancer in children with AIDS. AIDS-Cancer Match Registry Study Group. JAMA 2000; 284:205-9.
22. Pollock BH, Jenson HB, Leach CT, et al. Risk factors for pediatric human immunodeficiency virus-related malignancy. JAMA 2003; 289:2393-9.
23. Righetti E, Ballon G, Ometto L, et al. Dynamics of Epstein-Barr virus in HIV-1-infected subjects on highly active antiretroviral therapy. AIDS 2002; 16:63-73.
24. Kest H, Brogly S, McSherry G, Dashefsky B, Oleske J, Seage GR 3rd. Malignancy in perinatally human immunodeficiency virus-infected children in the United States. Pediatr Infect Dis J 2005; 24:237-42.
25. Bruyand M, Thiebaut R, Lawson-Ayayi S, et al. Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretro-viral therapy era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort. Clin Infect Dis 2009; 49:1109-16.
26. Gichuhi C, Obimbo E, Mbori-Ngacha D, et al. Predictors of mortality in HIV-1 exposed uninfected post-neonatal infants at the Kenyatta National Hospital, Nairobi. East Afr Med J 2005; 82:447-51.
27. Obimbo EM, Mbori-Ngacha DA, Ochieng JO, et al. Predictors of early mortality in a cohort of human immunodeficiency virus type 1-infected African children. Pediatr Infect Dis J 2004; 23:536-43.
28. John-Stewart GC. Strategic approaches to decrease breast milk transmission of HIV-1: the importance of small things. J Infect Dis 2009; 200:1487-9.
29. Shaffer N, Chuachoowong R, Mock PA, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Lancet 1999; 353:773-780.
30. DeVange Panteleeff D, John G, Nduati RW, et al. Rapid method for screening dried blood samples on filter paper for HIV type 1 DNA. J Clin Microbiol 1999; 37:350-353.
31. Emery S, Bodrug S, Richardson BA, et al. Evaluation of performance of the Gen-Probe HIV type 1 viral load assay using primary subtype A, C, and D isolates from Kenya. J Clinical Microbiol 2000; 38:2688-2695.
32. Kimura H, Morita M, Yabuta Y, et al. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 1999; 37:132-6.
33. Sumaya CV, Henle W, Henle G, Smith MH, LeBlanc D. Seroepidemio-logic study of Epstein-Barr virus infections in a rural community. J Infect Dis 1975; 131:403-8.
34. Crowcroft NS, Vyse A, Brown DW, Strachan DP. Epidemiology of Epstein-Barr virus infection in pre-adolescent children: application of a new salivary method in Edinburgh, Scotland. J Epidemiol Community Health 1998; 52:101-4.
35. Alsip GR, Ench Y, Sumaya CV, Boswell RN. Increased Epstein-Barr virus DNA in oropharyngeal secretions from patients with AIDS, AIDS-related complex, or asymptomatic human immunodeficiency virus infections. J Infect Dis 1988; 157:1072-6.
36. Diaz-Mitoma F, Ruiz A, Flowerdew G, et al. High levels of Epstein-Barr virus in the oropharynx: a predictor of disease progression in human immunodeficiency virus infection. J Med Virol 1990; 31:69-75.
37. Farquhar C, Nduati R, Haigwood N, et al. High maternal HIV-1 viral load during pregnancy is associated with reduced placental transfer of measles IgG antibody. J Acquir Immune Defic Syndr 2005; 40:494-7.
38. Brandt CD, Sison AV, Rakusan TA, et al. Epstein-Barr virus DNA in the blood of infants, young children, and adults by age and HIV status. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17:69-72.
39. Minhas V, Brayfield BP, Crabtree KL, Kankasa C, Mitchell CD, Wood C. Primary gamma-herpesviral infection in Zambian children. BMC Infect Dis 2010; 10:115.
40. Nakai H, Kawamura Y, Sugata K, et al. Host factors associated with the kinetics of Epstein-Barr virus DNA load in patients with primary Epstein-Barr virus infection. Microbiol Immunol 2012; 56:93-8.
41. Filteau S. The HIV-exposed, uninfected African child. Trop Med Int Health 2009; 14:276-87.